Back Above 393, ISRG +2.55% and Closing In on $458

$Intuitive Surgical(ISRG)$

$Intuitive Surgical(ISRG) +2.55% Surges Past $393 as MACD Golden Cross Confirms Upside, $458 Resistance Eyed

📊 Latest Close Data ISRG closed at $393.33 (+2.55%) on Sep 20, 2026, with volume reaching 4.93M shares (Volume Ratio 2.00), signaling heavy accumulation. The stock now trades 34.9% below its 52-week high of $603.88, but has staged a powerful recovery from the $328.57 52-week low.

🔥 Core Market Drivers UBS upgraded ISRG to Buy with a $500 target, arguing hospital capex fears are overblown. Management's recent call signaled overseas lease rates will "rise over time," while a new Malaysia production facility (2028) underscores Asia-Pacific expansion confidence. Q2 EPS of $2.80 beat estimates by 12%.

📈 Technical Analysis The MACD just flashed a golden cross with DIF surpassing DEA (MACD histogram +6.24), confirming bullish momentum after weeks of contraction. RSI-6 surged to 78.4 (overbought but strong trend), while RSI-12 at 63.7 supports continued upside. KDJ-J at 113.6 shows extreme short-term strength—watch for potential pullback.

🎯 Key Price Levels

  • Primary Support: $365.34 (Sep 18 pivot low)

  • Strong Resistance: $457.93 (Sep 18 swing high)

  • Immediate Pivot: $381.51 (today's open, now breakout zone)

💰 Valuation Perspective P/E TTM stands at 45.1 vs. forward P/E of just 36.49, which is 1.8 standard deviations below the historical average of 59.04—suggesting significant undervaluation relative to its own growth trajectory. P/S of 12.64 remains premium but justifiable for robotic surgery leadership.

🏦 Analyst Targets 29 analysts maintain overwhelming bullish conviction: 11 Strong Buy, 13 Buy, 9 Hold, 1 Underperform. Average target is $480.77, representing 22% upside from current levels. Highest target of $685 suggests substantial long-term optionality.

📅 Weekly Outlook Expect a trading range of $375–$415. A decisive breakout above $395 could trigger rapid advance toward the $430–$458 resistance zone. Failure to hold $379.50 (today's low) would signal a retest of the $365 support shelf. Given MACD momentum and institutional accumulation, bias remains bullish above $381.

Disclaimer: This is not investment advice. Technical analysis involves inherent uncertainty. Always conduct independent research and manage risk appropriately.

🎯$Intuitive Surgical(ISRG) Options Strategy:Bull Call Spread

  • Underlying: ISRG

  • View: Bullish / Momentum Continuation (MACD Golden Cross confirmed, RSI strong trend, UBS upgrade to Buy)

  • Strategy Type: Debit Spread (Defined Risk, Directional)

  • Option Contract Portfolio:

    • Buy 1x ISRG Sep 25, 2026 $390 Call @ ~$3.33 (mid $8.15 — wait, using realistic mid-prices from option chain: Buy 390C @ $3.33, Sell 400C @ $0.05 — this creates virtually no credit offset)

    • Better calibrated: Buy 1x Sep 25 $385 Call @ ~$8.33 mid, Sell 1x Sep 25 $400 Call @ ~$0.05 mid

    • Net Debit: ~$8.28 per spread (using mid-prices from option chain: $8.33 - $0.05 = $8.28)

  • Max Gain & Loss:

    • Max Gain: $1,500 - $828 = $672 per contract (strike width $15 × 100)

    • Max Loss: $828 per contract (net debit paid)

  • Initial Cost/Credit: Net Debit ~$8.28 ($828 per contract)


Markets are always moving - and sometimes, the best move is knowing what works for you.

With Treasury yields, oil prices and rate expectations keeping markets on edge this week, investors are once again thinking carefully about where to position next. There’s no one-size-fits-all choice in investing — and the same goes for Tiger Merch. This month’s hot picks are in, featuring the Tiger Toiletry Bag, Universal Travel Adapter, Tiger Umbrella and more favourites chosen by fellow Tigers.

Explore the Monthly Hot Picks in Tiger Coin Mall, now 12% OFF for a limited time.

https://laohu8.com/J/redeemGift?goodID=100561&type=delivery

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet